Search research articles
Contact Us
Filters
Showing results (101-110 of 222) with videos related to
Page
of 23
Sort By:
Gynecologic Oncology
|
May 22, 2012
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum
Julie A Deloia, Nikhil R Bhagwat, Kathleen M Darcy, et al.
Law and Human Behavior
|
June 27, 2017
Sexual misconduct in prison: What factors affect whether incarcerated women will report abuses committed by prison staff?
Sheryl P Kubiak, Hannah J Brenner, Deborah Bybee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2020
Age and racial differences in the presentation of gestational trophoblastic neoplasia
Elisabeth Diver, Michael Richardson, Cheng-I Liao, et al.
Gynecologic Oncology
|
January 7, 2015
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
Pang-ning Teng, Nicholas W Bateman, Kathleen M Darcy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer
Thomas C Krivak, Kathleen M Darcy, Chunqiao Tian, et al.
Gynecologic Oncology
|
June 16, 2009
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study
Kathleen M Darcy, William E Brady, Jan K Blancato, et al.
Psychosomatic Medicine
|
September 25, 2012
Set-shifting among adolescents with bulimic spectrum eating disorders
Alison M Darcy, Kathleen Kara Fitzpatrick, Danielle Colborn, et al.
Gynecologic Oncology
|
September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study
Elizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology
|
January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
Jennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Military Medicine
|
February 12, 2026
Age Comparisons of Endometrial Cancer Clinicopathology and Treatment in the United States Military Health System
Yvonne L Eaglehouse, Kathleen M Darcy, Kimberly R Robins, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 222) with videos related to
Sort By:
Page
of 23
Gynecologic Oncology
|
May 22, 2012
Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum
Julie A Deloia, Nikhil R Bhagwat, Kathleen M Darcy, et al.
Law and Human Behavior
|
June 27, 2017
Sexual misconduct in prison: What factors affect whether incarcerated women will report abuses committed by prison staff?
Sheryl P Kubiak, Hannah J Brenner, Deborah Bybee, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 14, 2020
Age and racial differences in the presentation of gestational trophoblastic neoplasia
Elisabeth Diver, Michael Richardson, Cheng-I Liao, et al.
Gynecologic Oncology
|
January 7, 2015
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells
Pang-ning Teng, Nicholas W Bateman, Kathleen M Darcy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer
Thomas C Krivak, Kathleen M Darcy, Chunqiao Tian, et al.
Gynecologic Oncology
|
June 16, 2009
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study
Kathleen M Darcy, William E Brady, Jan K Blancato, et al.
Psychosomatic Medicine
|
September 25, 2012
Set-shifting among adolescents with bulimic spectrum eating disorders
Alison M Darcy, Kathleen Kara Fitzpatrick, Danielle Colborn, et al.
Gynecologic Oncology
|
September 22, 2009
Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study
Elizabeth L Jewell, Kathleen M Darcy, Alan Hutson, et al.
Gynecologic Oncology
|
January 13, 2009
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
Jennifer M Rubatt, Kathleen M Darcy, Alan Hutson, et al.
Military Medicine
|
February 12, 2026
Age Comparisons of Endometrial Cancer Clinicopathology and Treatment in the United States Military Health System
Yvonne L Eaglehouse, Kathleen M Darcy, Kimberly R Robins, et al.
Page
of 23